SG11201505536RA - Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases - Google Patents
Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseasesInfo
- Publication number
- SG11201505536RA SG11201505536RA SG11201505536RA SG11201505536RA SG11201505536RA SG 11201505536R A SG11201505536R A SG 11201505536RA SG 11201505536R A SG11201505536R A SG 11201505536RA SG 11201505536R A SG11201505536R A SG 11201505536RA SG 11201505536R A SG11201505536R A SG 11201505536RA
- Authority
- SG
- Singapore
- Prior art keywords
- heterocycle
- treatment
- methods
- viral diseases
- tetracyclic compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2013/000038 WO2014110687A1 (en) | 2013-01-16 | 2013-01-16 | Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| PCT/CN2013/001676 WO2014110705A1 (en) | 2013-01-16 | 2013-12-31 | Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505536RA true SG11201505536RA (en) | 2015-08-28 |
Family
ID=51208906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505536RA SG11201505536RA (en) | 2013-01-16 | 2013-12-31 | Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9555038B2 (en) |
| EP (1) | EP2945952B1 (en) |
| JP (3) | JP6093451B2 (en) |
| KR (1) | KR101748974B1 (en) |
| CN (1) | CN105073755B (en) |
| AP (1) | AP2015008625A0 (en) |
| AR (1) | AR094496A1 (en) |
| AU (1) | AU2013374112B2 (en) |
| BR (1) | BR112015016325A2 (en) |
| CA (1) | CA2898049C (en) |
| CL (1) | CL2015001971A1 (en) |
| CR (1) | CR20150378A (en) |
| DO (1) | DOP2015000169A (en) |
| EA (1) | EA030554B1 (en) |
| EC (1) | ECSP15035530A (en) |
| HK (1) | HK1211290A1 (en) |
| IL (1) | IL239832A0 (en) |
| MA (1) | MA38315B1 (en) |
| MD (1) | MD20150075A2 (en) |
| MX (1) | MX356203B (en) |
| PE (1) | PE20151892A1 (en) |
| PH (1) | PH12015501560A1 (en) |
| SG (1) | SG11201505536RA (en) |
| TN (1) | TN2015000293A1 (en) |
| TW (1) | TW201441231A (en) |
| WO (2) | WO2014110687A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014110687A1 (en) * | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| US10457690B2 (en) | 2015-06-04 | 2019-10-29 | Merck Sharp & Dohme Corp. | Process for preparing substituted tetracyclic heterocycle compounds |
| US20180228826A1 (en) * | 2015-08-04 | 2018-08-16 | Merck Sharp & Dohme Corp. | Fixed-dose combinations of antiviral compounds |
| US20180228828A1 (en) * | 2015-08-04 | 2018-08-16 | Merck Sharp & Dohme Corp. | Fixed-dose combinations of antiviral compounds |
| EP3393585A4 (en) * | 2015-12-21 | 2019-05-08 | Merck Sharp & Dohme Corp. | Silane-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
| WO2017181383A1 (en) | 2016-04-21 | 2017-10-26 | Merck Sharp & Dohme Corp. | Hepatitis c virus inhibitors |
| EP3473639B1 (en) * | 2016-06-21 | 2023-03-29 | Zhejiang Palo Alto Pharmaceuticals, Inc | Hepatitis c virus inhibitor and application |
| WO2018032468A1 (en) * | 2016-08-18 | 2018-02-22 | Merck Sharp & Dohme Corp. | Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| WO2018032467A1 (en) | 2016-08-18 | 2018-02-22 | Merck Sharp & Dohme Corp. | Chromane-substitued tetracyclic compounds and uses thereof for treatment of viral diseases |
| CN109206396B (en) * | 2017-07-05 | 2023-03-28 | 上海迪赛诺化学制药有限公司 | Preparation method of 2-C-methyl-4,5-O- (1-methylvinyl) -D-arabinonic acid ethyl ester |
| CN109232612A (en) * | 2017-07-11 | 2019-01-18 | 周龙兴 | Inhibit compound, the medical composition and its use of hepatitis C virus |
| EP3870183A4 (en) * | 2018-10-26 | 2022-07-20 | Merck Sharp & Dohme Corp. | Formulations of antiviral compounds |
| WO2022266497A1 (en) * | 2021-06-17 | 2022-12-22 | Atea Pharmaceuticals, Inc. | Advantageous anti-hcv combination therapy |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3927630B2 (en) | 1996-09-27 | 2007-06-13 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Preventive and therapeutic agents for viral infections |
| PL359920A1 (en) | 2000-09-20 | 2004-09-06 | Merck Patent Gmbh | 4-amino-quinazolines |
| KR20060033904A (en) | 2003-07-10 | 2006-04-20 | 패러다임 테라퓨틱스 리미티드 | Silicon compounds and their use |
| US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| ES2322602T3 (en) | 2004-02-24 | 2009-06-23 | Japan Tobacco, Inc. | CONDENSED HETEROTETHYCLIC COMPOUNDS AND ITS USE AS AN HCV POLYMERASE INHIBITOR. |
| WO2007084413A2 (en) | 2004-07-14 | 2007-07-26 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| US7153848B2 (en) | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
| WO2006046030A2 (en) | 2004-10-26 | 2006-05-04 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Tetracyclic indole derivatives as antiviral agents |
| GB2438802A (en) | 2005-02-28 | 2007-12-05 | Univ Rockefeller | Structure of the hepatitis C virus NS5A protein |
| US7994360B2 (en) | 2005-05-16 | 2011-08-09 | Xtl Biopharmaceuticals Ltd. | Benzofuran compounds |
| US20110104109A1 (en) | 2005-07-13 | 2011-05-05 | Frank Bennett | Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| CA2612442A1 (en) | 2005-07-14 | 2007-01-18 | Irm Llc | Heterotetracyclic compounds as tpo mimetics |
| US7473784B2 (en) | 2005-08-01 | 2009-01-06 | Bristol-Myers Squibb Company | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| FR2894963A1 (en) | 2005-12-16 | 2007-06-22 | Inst Nat Sante Rech Med | NEW COMPOUNDS INTERACTING WITH PEA-15 |
| US7745636B2 (en) | 2006-08-11 | 2010-06-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US20110130361A1 (en) | 2007-08-09 | 2011-06-02 | Jonathan Grimm | Silicon derivatives as histone deacetylase inhibitors |
| US7642251B2 (en) | 2007-08-09 | 2010-01-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US20090176778A1 (en) | 2007-08-10 | 2009-07-09 | Franz Ulrich Schmitz | Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| JP5312486B2 (en) | 2008-02-13 | 2013-10-09 | ブリストル−マイヤーズ スクイブ カンパニー | Hepatitis C virus inhibitor |
| US7704992B2 (en) | 2008-02-13 | 2010-04-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| DK2540350T3 (en) | 2008-07-22 | 2014-08-04 | Merck Sharp & Dohme | COMBINATIONS OF A MACROCYCLIC QUINOXAL COMPOUND, WHICH IS ANHCV-NS3 PROTEASE INHIBITOR WITH OTHER HCV AGENTS |
| WO2010041687A1 (en) | 2008-10-09 | 2010-04-15 | コニカミノルタホールディングス株式会社 | Organic photoelectric conversion element, solar cell, and optical sensor array |
| WO2010062821A1 (en) | 2008-11-28 | 2010-06-03 | Glaxosmithkline Llc | Anti-viral compounds, compositions, and methods of use |
| CN104163816A (en) | 2008-12-03 | 2014-11-26 | 普雷西迪奥制药公司 | Inhibitors of HCV NS5A |
| CA2755658A1 (en) | 2009-03-27 | 2010-09-30 | Presidio Pharmaceuticals, Inc. | Fused ring inhibitors of hepatitis c |
| US8563513B2 (en) | 2009-03-27 | 2013-10-22 | Van Andel Research Institute | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
| SI2410844T1 (en) * | 2009-03-27 | 2016-06-30 | Merck Sharp & Dohme Corp. | Inhibitors of hepatitis c virus replication |
| AU2010253790A1 (en) | 2009-05-29 | 2011-12-15 | Merck Sharp & Dohme Corp. | Antiviral compounds composed of three aligned aryl moieties to treat diseases such as Hepatitis C |
| US8221737B2 (en) | 2009-06-16 | 2012-07-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| US8377980B2 (en) | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2011087740A1 (en) | 2009-12-22 | 2011-07-21 | Schering Corporation | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases |
| US8609635B2 (en) | 2010-03-09 | 2013-12-17 | Merck Sharp & Dohme Corp. | Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| MX2013003634A (en) * | 2010-09-29 | 2013-05-20 | Merck Sharp & Dohme | Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases. |
| WO2012041014A1 (en) * | 2010-09-29 | 2012-04-05 | Merck Sharp & Dohme Corp. | Tetracyclic indole derivatives for treating hepatitis c virus infection |
| WO2012040923A1 (en) * | 2010-09-29 | 2012-04-05 | Merck Sharp & Dohme Corp. | Tetracyclic indole derivatives and methods of use thereof for the treatment of viral diseases |
| WO2014110687A1 (en) * | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| WO2014110688A1 (en) * | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Thiophene- sub stitued tetracyclic compounds and methods of use thereof for the treatment of viral diseases |
-
2013
- 2013-01-16 WO PCT/CN2013/000038 patent/WO2014110687A1/en active Application Filing
- 2013-12-31 JP JP2015551946A patent/JP6093451B2/en not_active Expired - Fee Related
- 2013-12-31 CA CA2898049A patent/CA2898049C/en not_active Expired - Fee Related
- 2013-12-31 SG SG11201505536RA patent/SG11201505536RA/en unknown
- 2013-12-31 AP AP2015008625A patent/AP2015008625A0/en unknown
- 2013-12-31 US US14/761,256 patent/US9555038B2/en active Active
- 2013-12-31 EP EP13871363.1A patent/EP2945952B1/en active Active
- 2013-12-31 EA EA201591328A patent/EA030554B1/en not_active IP Right Cessation
- 2013-12-31 PE PE2015001352A patent/PE20151892A1/en not_active Application Discontinuation
- 2013-12-31 MD MDA20150075A patent/MD20150075A2/en not_active Application Discontinuation
- 2013-12-31 WO PCT/CN2013/001676 patent/WO2014110705A1/en active Application Filing
- 2013-12-31 CN CN201380074735.2A patent/CN105073755B/en not_active Expired - Fee Related
- 2013-12-31 AU AU2013374112A patent/AU2013374112B2/en not_active Ceased
- 2013-12-31 MA MA38315A patent/MA38315B1/en unknown
- 2013-12-31 BR BR112015016325A patent/BR112015016325A2/en not_active Application Discontinuation
- 2013-12-31 MX MX2015009225A patent/MX356203B/en active IP Right Grant
- 2013-12-31 KR KR1020157021818A patent/KR101748974B1/en active IP Right Grant
-
2014
- 2014-01-16 TW TW103101674A patent/TW201441231A/en unknown
- 2014-01-16 AR ARP140100153A patent/AR094496A1/en unknown
-
2015
- 2015-06-29 TN TNP2015000293A patent/TN2015000293A1/en unknown
- 2015-07-08 IL IL239832A patent/IL239832A0/en unknown
- 2015-07-13 PH PH12015501560A patent/PH12015501560A1/en unknown
- 2015-07-13 CL CL2015001971A patent/CL2015001971A1/en unknown
- 2015-07-16 DO DO2015000169A patent/DOP2015000169A/en unknown
- 2015-07-16 CR CR20150378A patent/CR20150378A/en unknown
- 2015-08-17 EC ECIEPI201535530A patent/ECSP15035530A/en unknown
- 2015-12-08 HK HK15112117.6A patent/HK1211290A1/en unknown
-
2016
- 2016-11-07 JP JP2016217169A patent/JP6148779B2/en not_active Expired - Fee Related
- 2016-11-18 JP JP2016225137A patent/JP6417380B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL239832A0 (en) | Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
| HK1216421A1 (en) | Therapeutic compounds for the treatment of viral infections | |
| HK1207636A1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| HK1210463A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
| HK1215681A1 (en) | Methods of using interleukin-10 for treating diseases and disorders -10 | |
| HK1220324A1 (en) | Methods, compounds, and compositions for the treatment of angiotensin-related diseases | |
| IL231217A0 (en) | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases | |
| EP2968321A4 (en) | Compounds for treatment of fibrosis diseases | |
| EP2753611A4 (en) | Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases | |
| EP2953456A4 (en) | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c | |
| EP2943189A4 (en) | Methods and comp0stions for treatment of demyelinating diseases | |
| EP2945953A4 (en) | Thiophene-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
| HK1225385A1 (en) | Heteroaryl derivatives for the treatment of respiratory diseases | |
| EP3013834A4 (en) | Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases | |
| EP2953462A4 (en) | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c | |
| EP3013334A4 (en) | Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases | |
| HK1216881A1 (en) | Pyridone derivatives for the treatment of viral infections and further diseases | |
| GB201309375D0 (en) | Medical methods and compounds for medical use | |
| IL243637A0 (en) | Ppar-sparing compounds for the treatment of metabolic diseases | |
| EP3083634A4 (en) | Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases | |
| EP2986294A4 (en) | Compounds for treatment of pain | |
| EP2953461A4 (en) | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c | |
| EP2994461A4 (en) | Methods of treating skin conditions using cyclolignan compounds | |
| EP3013333A4 (en) | Heterocyclic compounds and methods of use thereof for the treatment of hepatitis c | |
| EP2943593A4 (en) | Diagnosis and treatment of viral diseases |